Purchase Order 36C77020P0147
Award Date 11/12/19
Potential Completion Date 11/20/19
Potential Value $96K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
Partial Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Kennesaw, GA 30144, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $679,770 firm-fixed-price purchase order to Tri-Pharma, Inc. to distribute ranitidine 150mg tablets to all VA Consolidated Mail-Out Pharmacy (CMOP) facilities. This award was made under an unrestricted solicitation, RFQ CMOP National Office Consolidated Rx 36C77020Q0082, with a 10-day delivery requirement. Tri-Pharma, a minority-owned, small disadvantaged business, has provided pharmaceutical and medical supplies to...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order contract to Tri-Pharma, Inc., a minority-owned small disadvantaged business, to provide pharmaceuticals. The $698,425.00 contract has a completion date of June 3, 2019 and does not include a set-aside designation. Tri-Pharma is a specialty pharmaceutical wholesaler that has provided products such as RYDAPT tablets, fludarabine, and ranitidine to VA medical centers and the NIH Clinical...
- This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business, to provide pharmaceutical products. The $244,500.00 contract has a performance period ending on March 25, 2019 and does not have a set-aside designation. Tri-Pharma has provided pharmaceuticals such as RYDAPT tablets, fludarabine, and ranitidine to VA Medical Centers and the NIH Clinical Center under...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of pharmaceuticals. The contract has a potential value of $698,075.00 and a completion date of June 3, 2019. Tri-Pharma has previously provided pharmaceutical products and personal protective equipment to various government agencies, including the VA and the Department of Health and Human...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of pharmaceuticals. The $698,075.00 contract does not have a set-aside designation and was completed on June 3, 2019. Tri-Pharma, a specialty pharmaceutical wholesaler, has provided various pharmaceutical products and medical supplies to the VA and Department of Health and Human Services under previous...
- This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to Tri-Pharma, Inc., a minority-owned, Hispanic American-owned small disadvantaged business corporation. The $15,500 contract is for the delivery of pharmaceutical and medical supply products, including items like SANDOSTATIN, RYDAPT, fludarabine, ranitidine, and personal protective equipment such as N95 masks, surgical masks, and disinfectant wipes. The...
- This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Tri-Pharma, Inc., a minority-owned, self-certified small disadvantaged business. The contract, valued at $1,326,625.26, is for the supply of the pharmaceutical drug pantoprazole to all VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The contract does not have a set-aside designation and has an ultimate completion date of February 26, 2016. Tri-Pharma, Inc. is a Subchapter S...
- The U.S. Department of Health and Human Services National Institutes of Health Clinical Center awarded a $134,371.05 firm-fixed-price purchase order contract to Tri-Pharma, Inc., a minority-owned, small disadvantaged business. The contract, which has no set-aside designation, is for the delivery of pharmaceutical products such as RYDAPT tablets, fludarabine, and ranitidine to the NIH Clinical Center. Tri-Pharma, a specialty pharmaceutical wholesaler, has provided medical supplies and personal...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a firm fixed price purchase order to Tri-Pharma, Inc. doing business as Tri-Pharma Inc. valued at approximately $706,085 to refill critical needs for famotidine 20mg tablets. Under the terms of the contract, Tri-Pharma will deliver 480,000 famotidine tablets packaged in 1000 count bottles to seven different VA medical centers located in Hines, Illinois within 10 days of the...
- The Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order contract worth $562,100.00 to Tri-Pharma, Inc., a minority-owned, self-certified small disadvantaged business, for the delivery of the pharmaceutical drug buspirone. The contract was awarded under VA Network 15's solicitation for pharmaceutical products, which was set aside for service-disabled veteran-owned small businesses (SDVOSB). However, the final award to Tri-Pharma, Inc. did not utilize an SDVOSB set-aside....